Focused on training the next generation of public health workforce and improving the overall health and well-being of residents, the University of Texas Medical Branch is announcing its newly established School of Public and Population Health today.

Researchers at the University of Texas Medical Branch have developed a quick and affordable model to predict if a COVID-19 patient will get a more severe case of the disease.

People with a specific type of low-risk bladder cancer may be getting additional tests and treatments with little to no medical benefit, a new JAMA article reports.

Scientists at the University of Texas Medical Branch have developed a vaccine showing promising protection against Nipah virus, a zoonotic virus that has a mortality rate as high as 70 percent and that is considered to be a pathogen of pandemic potential. The study was published in Proceedings of the National Academy of Sciences.

The University of Texas Medical Branch is naming its School of Medicine the John Sealy School of Medicine in honor of the 19th century Texas entrepreneur and philanthropist John Sealy and the foundation that was established decades after his death to continue his legacy of support. Over the past 100 years, The Sealy & Smith Foundation has contributed more than $1 billion to UTMB, one of the largest cumulative contributions in history to an American institution.

In a new study published in the Journal of the American Medical Association Oncology, researchers found evidence that HPV vaccination is reducing the incidence of anal cancer among young adults in the US.

Researchers at the University of Texas Medical Branch have developed a method to detect regionally emerging COVID-19 variants that could guide treatment and vaccine design.

The University of Texas Medical Branch (UTMB) named Dr. Melinda Sheffield-Moore as senior vice president and dean of the Graduate School of Biomedical Sciences.

In a study published Jan. 12 in Scientific Reports from Nature, UTMB researchers describe how they developed a behavioral test to determine anosmia—the loss of the sense of smell—for hamsters that were infected with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).

The Level 1 Neonatal Facility Designation reflects the facility’s documented capabilities and history of providing a specific level of care to infants.